Search PDMR transactions

Notifier
Name of person with notification obligation
Mats Lundgren
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Mats Lundgren
Position
Deputy CEO/Deputy Managing Director
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Abera Bioscience AB
Issuer´s LEI code
549300IO3Q8IE2FDUS29
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Abera Bioscience SE0015245097 Acquisition 7,000 Quantity 8.02 SEK 13/05/2022 SPOTLIGHT STOCK MARKET
Share Abera Bioscience SE0015245097 Acquisition 6,000 Quantity 8.01 SEK 13/05/2022 SPOTLIGHT STOCK MARKET
Share Abera Bioscience SE0015245097 Acquisition 6,535 Quantity 7.90 SEK 16/05/2022 SPOTLIGHT STOCK MARKET
Share Abera Bioscience SE0015245097 Acquisition 856 Quantity 8.29 SEK 17/05/2022 SPOTLIGHT STOCK MARKET
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Abera Bioscience SE0015245097 Acquisition 13/05/2022 SPOTLIGHT STOCK MARKET 13,000 (Quantity) 8.01538462 SEK
Abera Bioscience SE0015245097 Acquisition 16/05/2022 SPOTLIGHT STOCK MARKET 6,535 (Quantity) 7.90 SEK
Abera Bioscience SE0015245097 Acquisition 17/05/2022 SPOTLIGHT STOCK MARKET 856 (Quantity) 8.29 SEK
<< Back